2021 The first wave of salary adjustment plans for pharmaceutical companies is coming!

Today, there is news that the headquarters of Viatris specially approved a salary increase in China.

Huizhi is a new company established by Pfizer Prejohnson and Mylan in November 2020, and Pfizer holds 57% of the shares.

In the current environment, the news of Huizhi's gains came to the industry to feel a little surprised.

It is reported that in 2020, Pfizer will raise salaries at the beginning and end of the year, respectively, at 8% at the beginning of the year and nearly 20% at the end of the year.

Pfizer's large-scale work may be related to its beautiful performance.

The announcement showed that Pfizer’s fourth-quarter revenue was 11.

Today, Huizhi's salary increase has no actual results, but the rumors of salary increase further confirm its importance to the Chinese market.

We must know that in December 2020, in order to streamline operations and increase profits, Huizhi, which was just one month old, began to drastically reduce costs.

However, in addition to the good news of the salary increase, there is also news that Huizhi reduced the county travel subsidy from 2,600 to 1,150 in February this year.

How much did Huizhi actually rise in the end? Isn't it such a good welfare? To be announced after the actual wages are paid.

But in any case, the rumors of salary increases are at least encouraging.

In addition to salary increases, it is reported that this year, pharmaceutical companies have announced salary cuts.

Reference source: Brother Luo Shi, "Representatives of Division V are going to raise their salaries! 》